Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction
Drug-drug interactions are one of the major risk factors associated with statin-induced myopathy. Although simvastatin is widely used in Thailand, studies investigating the prevalence of potential simvastatin-drug interactions (SDIs) and its clinical relevance in Thai population are still limited. W...
Main Authors: | Methira Siriangkhawut, Patthana Tansakul, Verawan Uchaipichat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Saudi Pharmaceutical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319016416301402 |
Similar Items
-
Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
by: Ying Li, et al.
Published: (2019-04-01) -
First reported case of rhabdomyolysis associated with concomitant use of cyclosporin, diltiazem, and simvastatin
by: Kar Wah Fuah, et al.
Published: (2021-01-01) -
Effect of Pomelo Juice on the Pharmacokinetics of Simvastatin, CYP3A2 Activity and Mdr1a, Mdr1b and Slc21a5 Expressions in Rats
by: Kritsakorn Rayasilp, et al.
Published: (2019-12-01) -
Investigation of the Inhibitory Effect of Simvastatin on the Metabolism of Lidocaine Both in vitro and in vivo
by: Wang Y, et al.
Published: (2020-05-01) -
Simultaneous administration of fluoxetine and simvastatin ameliorates lipid profile, improves brain level of neurotransmitters, and increases bioavailability of simvastatin
by: Al-Asmari AK, et al.
Published: (2017-04-01)